WRF
GMAB icon

Waddell & Reed Financial’s Genmab GMAB Stock Holding History

Waddell & Reed Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$137M Buy
4,159,715
+1,078,942
+35% +$40.6M 0.28% 98
2020
Q4 		$125M Buy
3,080,773
+62,467
+2% +$2.34M 0.26% 106
2020
Q3 		$111M Buy
3,018,306
+237,119
+9% +$8.57M 0.27% 102
2020
Q2 		$94.3M Buy
2,781,187
+1,240,989
+81% +$33.8M 0.24% 118
2020
Q1 		$32.6M Buy
+1,540,198
New +$34.3M 0.11% 220

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Waddell & Reed Financial's GMAB Position: Q1 2021 in Review

Waddell & Reed Financial increased its Genmab (GMAB) stake by 35% in Q1 2021, buying an estimated $40.6M and bringing the position to 4,159,715 shares worth $137M. The position accounts for 0.28% of the portfolio, ranked #98.

Waddell & Reed Financial first reported a position in GMAB in Q1 2020 and has held it in 5 quarters since. 210 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Waddell & Reed Financial held 4,159,715 shares of Genmab worth $137M as of Q1 2021.
  • Waddell & Reed Financial bought 1,078,942 Genmab shares in Q1 2021, an estimated $40.6M.
  • Genmab made up 0.28% of Waddell & Reed Financial's portfolio in Q1 2021, its #98 holding.
  • Waddell & Reed Financial first reported a position in Genmab in Q1 2020 and has held it in 5 quarters since.
  • 210 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.